DVBCWLL7.m

DVBCWLL7 ;ALB/RLC LIVER, GALL BLADDER AND PANCREAS WKS TEXT - 1 ; 12 FEB 2007

 ;;2.7;AMIE;**121**;Apr 10, 1995;Build 9

 ;

 ;

TXT ;

 ;;C. Physical Examination (Objective Findings): 

 ;;

 ;;Address each of the following as appropriate, and fully describe current

 ;;findings: 

 ;;

 ;;   1. Abdominal Exam

 ;;

 ;;      a. Describe any areas of tenderness and/or organomegaly, including liver

 ;;         size and whether it is tender to palpation. 

 ;;      b. Presence or absence of ascites 

 ;;      c. Evidence of Portal Hypertension (e.g. superficial abdominal veins,

 ;;         splenomegaly, abdominal pain) 

 ;;

 ;;   2. General exam

 ;;

 ;;      a. Describe all other signs of liver disease (e.g. jaundice, palmar

 ;;         erythema, spider angiomata). 

 ;;      b. Evidence of Malnutrition (e.g. muscle wasting)

 ;; 

 ;;D. Diagnostic and Clinical Tests: 

 ;;

 ;;   1. For esophageal varices, X-ray, endoscopy, etc.

 ;;

 ;;   2. For gall bladder disease, X-ray or other objective confirmation.

 ;;

 ;;   3. For liver disease: 

 ;;

 ;;      a. serologic tests for hepatitis as appropriate (e.g. HbsAg,

 ;;         anti-HCV, anti-HBc, ferritin, alpha-fetoprotein); liver imaging

 ;;         as appropriate, (e.g. ultrasound or abdominal CT scan), biopsy

 ;;         report (when available). 

 ;;

 ;;      b. Viral hepatitis (including Hepatitis C): Name the specific type

 ;;         (A, B, C, or other). For hepatitis B and / or hepatitis C,

 ;;         provide an opinion as to which risk factor is the most likely

 ;;         cause, and whether these risk factors were present during the

 ;;         veteran's time in the military. Please support your opinion by

 ;;         discussing all risk factors in the individual and your rationale

 ;;         for your opinion. If you cannot determine which risk factor is

 ;;         the likely cause, state that there is no risk factor that is

 ;;         more likely than another to be the cause, and explain.

 ;;

 ;;      c. Hepatitis C: Please note that Hepatitis C generally does not

 ;;         produce clinically evident hepatitis at the time of infection.

 ;;         Please provide results of serologic (anti-HCV antibody) and

 ;;         viral (HCV RNA) testing for hepatitis C. The anti-HCV assay

 ;;         confirms exposure to hepatitis C but does not differentiate

 ;;         between chronic, acute, or resolved infection. False positive

 ;;         and false negative results occur, but rarely. A positive

 ;;         qualitative or quantitative HCV RNA assay indicates current

 ;;         hepatitis C infection. A negative qualitative HCV RNA assay

 ;;         indicates that the individual does not have active, chronic

 ;;         hepatitis C. The recombinant immunoblot assay (RIBA) is a

 ;;         confirmatory serologic test that establishes the diagnosis of

 ;;         past (resolved) infection if the anti-HCV is positive but the

 ;;         HCV RNA assay is negative.

 ;; 

 ;;The following are established risk factors for acquisition of hepatitis C

 ;;infection:

 ;;

 ;;  -Blood transfusion before 1992 

 ;;  -Past or present intravenous drug use 

 ;;  -Blood exposure of skin or mucous membranes including accidental needle

 ;;   punctures 

 ;;  -Sexual transmission (though most studies have failed to identify sexual

 ;;   transmission of this agent). Sexual transmission appears to be confined

 ;;   to such subgroups as persons with multiple sexual partners and sexually

 ;;   transmitted diseases. 

 ;;  -History of hemodialysis 

 ;;  -Tattoo or repeated body piercing 

 ;;  -History of intranasal cocaine use

 ;; 

 ;;See Harrison's Principles of Internal Medicine, 15th edition, The McGraw Hill

 ;;Companies, Inc., page 1709, 1729-1730.

 ;;

 ;;Please consider the veteran's potential for skin and mucous membrane exposure

 ;;to blood, especially where the veteran was a military corpsman, a medical

 ;;worker, or a combat veteran.

 ;;

 ;;      d. Cirrhosis, chronic hepatitis, liver malignancy, or other chronic

 ;;         liver disease: State the most likely etiology.  Address the

 ;;         relationship of the disease to active service, including any

 ;;         hepatitis that occurred in service.

 ;;

 ;;   4. Include results of all diagnostic and clinical tests conducted in the

 ;;      examination report.

 ;;

 ;;E. Diagnosis:

 ;;

 ;;

 ;;

 ;;Signature:                                         Date:

--- Routine Detail   --- with STRUCTURED ROUTINE LISTING ---DVBCWLL7   4494     printed  Mar 13, 2025@20:57:01                                                                                                                                                                                                    Page 2

DVBCWLL7  ;ALB/RLC LIVER, GALL BLADDER AND PANCREAS WKS TEXT - 1 ; 12 FEB 2007

 +1       ;;2.7;AMIE;**121**;Apr 10, 1995;Build 9

 +2       ;

 +3       ;

TXT       ;

 +1       ;;C. Physical Examination (Objective Findings): 

 +2       ;;

 +3       ;;Address each of the following as appropriate, and fully describe current

 +4       ;;findings: 

 +5       ;;

 +6       ;;   1. Abdominal Exam

 +7       ;;

 +8       ;;      a. Describe any areas of tenderness and/or organomegaly, including liver

 +9       ;;         size and whether it is tender to palpation. 

 +10      ;;      b. Presence or absence of ascites 

 +11      ;;      c. Evidence of Portal Hypertension (e.g. superficial abdominal veins,

 +12      ;;         splenomegaly, abdominal pain) 

 +13      ;;

 +14      ;;   2. General exam

 +15      ;;

 +16      ;;      a. Describe all other signs of liver disease (e.g. jaundice, palmar

 +17      ;;         erythema, spider angiomata). 

 +18      ;;      b. Evidence of Malnutrition (e.g. muscle wasting)

 +19      ;; 

 +20      ;;D. Diagnostic and Clinical Tests: 

 +21      ;;

 +22      ;;   1. For esophageal varices, X-ray, endoscopy, etc.

 +23      ;;

 +24      ;;   2. For gall bladder disease, X-ray or other objective confirmation.

 +25      ;;

 +26      ;;   3. For liver disease: 

 +27      ;;

 +28      ;;      a. serologic tests for hepatitis as appropriate (e.g. HbsAg,

 +29      ;;         anti-HCV, anti-HBc, ferritin, alpha-fetoprotein); liver imaging

 +30      ;;         as appropriate, (e.g. ultrasound or abdominal CT scan), biopsy

 +31      ;;         report (when available). 

 +32      ;;

 +33      ;;      b. Viral hepatitis (including Hepatitis C): Name the specific type

 +34      ;;         (A, B, C, or other). For hepatitis B and / or hepatitis C,

 +35      ;;         provide an opinion as to which risk factor is the most likely

 +36      ;;         cause, and whether these risk factors were present during the

 +37      ;;         veteran's time in the military. Please support your opinion by

 +38      ;;         discussing all risk factors in the individual and your rationale

 +39      ;;         for your opinion. If you cannot determine which risk factor is

 +40      ;;         the likely cause, state that there is no risk factor that is

 +41      ;;         more likely than another to be the cause, and explain.

 +42      ;;

 +43      ;;      c. Hepatitis C: Please note that Hepatitis C generally does not

 +44      ;;         produce clinically evident hepatitis at the time of infection.

 +45      ;;         Please provide results of serologic (anti-HCV antibody) and

 +46      ;;         viral (HCV RNA) testing for hepatitis C. The anti-HCV assay

 +47      ;;         confirms exposure to hepatitis C but does not differentiate

 +48      ;;         between chronic, acute, or resolved infection. False positive

 +49      ;;         and false negative results occur, but rarely. A positive

 +50      ;;         qualitative or quantitative HCV RNA assay indicates current

 +51      ;;         hepatitis C infection. A negative qualitative HCV RNA assay

 +52      ;;         indicates that the individual does not have active, chronic

 +53      ;;         hepatitis C. The recombinant immunoblot assay (RIBA) is a

 +54      ;;         confirmatory serologic test that establishes the diagnosis of

 +55      ;;         past (resolved) infection if the anti-HCV is positive but the

 +56      ;;         HCV RNA assay is negative.

 +57      ;; 

 +58      ;;The following are established risk factors for acquisition of hepatitis C

 +59      ;;infection:

 +60      ;;

 +61      ;;  -Blood transfusion before 1992 

 +62      ;;  -Past or present intravenous drug use 

 +63      ;;  -Blood exposure of skin or mucous membranes including accidental needle

 +64      ;;   punctures 

 +65      ;;  -Sexual transmission (though most studies have failed to identify sexual

 +66      ;;   transmission of this agent). Sexual transmission appears to be confined

 +67      ;;   to such subgroups as persons with multiple sexual partners and sexually

 +68      ;;   transmitted diseases. 

 +69      ;;  -History of hemodialysis 

 +70      ;;  -Tattoo or repeated body piercing 

 +71      ;;  -History of intranasal cocaine use

 +72      ;; 

 +73      ;;See Harrison's Principles of Internal Medicine, 15th edition, The McGraw Hill

 +74      ;;Companies, Inc., page 1709, 1729-1730.

 +75      ;;

 +76      ;;Please consider the veteran's potential for skin and mucous membrane exposure

 +77      ;;to blood, especially where the veteran was a military corpsman, a medical

 +78      ;;worker, or a combat veteran.

 +79      ;;

 +80      ;;      d. Cirrhosis, chronic hepatitis, liver malignancy, or other chronic

 +81      ;;         liver disease: State the most likely etiology.  Address the

 +82      ;;         relationship of the disease to active service, including any

 +83      ;;         hepatitis that occurred in service.

 +84      ;;

 +85      ;;   4. Include results of all diagnostic and clinical tests conducted in the

 +86      ;;      examination report.

 +87      ;;

 +88      ;;E. Diagnosis:

 +89      ;;

 +90      ;;

 +91      ;;

 +92      ;;Signature:                                         Date: